FN1 and breast cancer: First, by targeting integrin α5β1, ATN-161, a pentapeptide, interferes with FN adhesion to integrin α5β1, thereby repressing prostate cancer and breast cancer angiogenesis, progression, and metastasis in vitro and in vivo (Chen, Zhao & Xie, 2022; Li et al., 2019).